{{flagHref}}
Products
  • Products
  • Categories
  • Blog
  • Podcast
  • Application
  • Document
|
/ {{languageFlag}}
Select language
Stanford Advanced Materials {{item.label}}
Stanford Advanced Materials
Select language
Stanford Advanced Materials {{item.label}}
a

Iron-catalysed tritiation of pharmaceuticals.

Title Iron-catalysed tritiation of pharmaceuticals.
Authors Renyuan Pony Yu, David Hesk, Nelo Rivera, István Pelczer, Paul J Chirik
Magazine Nature
Date 01/14/2016
DOI 10.1038/nature16464
Introduction A thorough understanding of a drug's pharmacokinetic and pharmacodynamic characteristics within animal models is essential for drug development. These evaluations are conducted both in vivo and in vitro across various stages of development, from preclinical absorption, distribution, metabolism, and excretion (ADME) studies to advanced human clinical trials. The objective is to clarify a drug molecule's metabolic profile and assess its toxicity. Radiolabelled compounds, particularly those containing (14)C or (3)H isotopes, serve as effective and commonly used diagnostic tools for these assessments. Introducing radiolabels through synthetic chemistry allows for direct tracking of the drug molecule without substantially altering its structure or function. Given the prevalence of C-H bonds in drugs and the relative simplicity and cost-effectiveness of tritium ((3)H), it remains an ideal radioisotope for early ADME studies in the drug development process. This paper presents an iron-catalysed method for the direct (3)H labelling of pharmaceuticals via hydrogen isotope exchange, utilising tritium gas as the radioisotope source. The iron catalyst displays site selectivity that differs from current iridium catalysts, enabling isotopic labelling at complementary positions within drug molecules and thus providing additional diagnostic capability in drug development.
Quote Renyuan Pony Yu, David Hesk and Nelo Rivera et al. Iron-catalysed tritiation of pharmaceuticals.. Nature. 2016. Vol. 529(7585). DOI: 10.1038/nature16464
Element Hydrogen (H) , Carbon (C) , Iridium (Ir)
Topics Biomedical Materials
Industry Pharmaceutical Industry , Chemical & Pharmacy , Research & Laboratory
Related papers
Loading... Please wait...
Publish your research and articles on the SAM website
Disclaimer
This site only provides metadata for academic works to enable users to easily find relevant information. For full access to the works, please use the DOI to visit the original publisher's website. The data comes from publicly accessible scientific databases and complies with the terms of use of these platforms. If you have any concerns regarding copyright, please contact us. We will address them immediately.

Success! You are now subscribed.

You have successfully subscribed! Check your inbox soon to receive great emails from this sender.
Leave A Message
Leave A Message
* Your Name:
* Your Email:
* Product Name:
* Your Phone:
* Comments: